Related Experiment Videos

Pharmacoeconomic burden of undertreating hypertension

Luca Degli Esposti1, Giorgia Valpiani

  • 1CliCon Srl, Health, Economics & Outcome Research, Ravenna, Italy. luca.degliesposti@clicon.it

Pharmacoeconomics
|September 15, 2004
PubMed

Insights

Undertreating hypertension leads to significant cardiovascular events and costs. More research is needed to quantify the economic and clinical impact of undertreatment and improve hypertension management.

Area of Science:

  • Pharmacoeconomics
  • Cardiovascular Medicine
  • Public Health

Background:

  • Antihypertensive drug therapy is crucial for reducing cardiovascular morbidity and mortality.
  • However, approximately 50% of hypertensive patients are undertreated or inadequately controlled.
  • Undertreatment of hypertension significantly impacts drug therapy effectiveness and cost-effectiveness.

Purpose of the Study:

  • To review the pharmacoeconomic burden of undertreating hypertension.
  • To identify key issues, measure undertreatment extent and associated costs.
  • To discuss essential aspects of hypertension disease management.

Main Methods:

  • Literature review focusing on pharmacoeconomic burden and undertreatment of hypertension.
  • Analysis of clinical and economic consequences of uncontrolled blood pressure.
  • Discussion of disease management strategies for hypertension.

Main Results:

  • The pharmacoeconomic burden of undertreating hypertension is substantial but under-researched.
  • Lack of epidemiological studies in clinical practice limits data availability.
  • Current data suggests significant clinical and economic losses due to inadequate hypertension control.

Conclusions:

  • Undertreatment of hypertension poses a major pharmacoeconomic challenge.
  • There is a critical need for more research, including appropriateness and cost-effectiveness studies.
  • Improved hypertension management is essential to mitigate clinical and economic consequences.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.